SOUTH SAN
FRANCISCO, Calif. --(BUSINESS WIRE)-- Exelixis, Inc. (NASDAQ: EXEL) today announced that renowned biomedical
research executive Maria C. Freire, Ph.D. has been elected to the company's Board of
Directors.
SOUTH SAN
FRANCISCO, Calif. — February 5, 2018 — FLX Bio, Inc., a biopharmaceutical company focused on the discovery and development of oral small molecule drugs to activate the immune system against cancer, today announced the appointment of senior pharmaceutical
research and development executive Michael F. Giordano, M.D., to its Board of
Directors.